Clinical trial
Open-Label Comparative Study of Risperidone Versus Olanzapine Versus Quetiapine…
NCT00182013 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00182013 |
|---|---|
| Title | Open-Label Comparative Study of Risperidone Versus Olanzapine Versus Quetiapine for Mania in Children and Adolescents With Bipolar I and Bipolar II Disorder |
| Lead sponsor | Massachusetts General Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Spectrum Disorder |
| Intervention type | Drug |
| Interventions | Risperidone, Olanzapine, Quetiapine |
| Enrollment | 106 |
| Start date | Jun 1, 2001 |
| Primary completion | Feb 1, 2004 |
| First posted | Sep 16, 2005 |
| Last update posted | Jun 13, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: